Eyelid ptosis enhanced after steroid pulse therapy in ocular myasthenia gravis: a case report

2015 ◽  
Vol 36 (6) ◽  
pp. 1055-1056
Author(s):  
Haruo Nishijima ◽  
Tatsuya Ueno ◽  
Chieko Suzuki ◽  
Masayuki Baba ◽  
Masahiko Tomiyama
Therapies ◽  
2020 ◽  
Author(s):  
Claire de Canecaude ◽  
Christophe Gazagne ◽  
Magali Paraire ◽  
Geneviève Durrieu

2017 ◽  
Vol 31 (7) ◽  
pp. 905-910
Author(s):  
Hiromitsu Nagano ◽  
Takashi Suda ◽  
Shinji Kaneda ◽  
Daisuke Tochii ◽  
Sachiko Tochii ◽  
...  

2021 ◽  
Vol 1 (1) ◽  
pp. 39-52
Author(s):  
Fikta Zakia Nurfaizah ◽  

Abstract Purpose: This study aimed to summarize the general history, physical exam findings, confirmation test, and treatment of a patient with juvenile ocular myasthenia gravis. Research Methodology: This article is a pediatric RSUD Abdoel Moeloek Lampung case report in April 2021. The subject of the case is a 3-year-old girl who is hospitalized in the hospital ward with juvenile ocular myasthenia gravis. Result: A 3-year-old girl, an inpatient in the Pediatric Ward, RSUD Abdoel Moeloek Lampung, with complaints of decreased left upper eyelid since three months ago. On physical examination, there was ptosis of the left superior palpebra. Prostigmine test was performed on day 2 of treatment in patients with positive test results. The patient was clinically diagnosed with “Juvenile Ocular Myasthenia Gravis.” Management of the patient during treatment was the injection of methylprednisolone 10 mg/12 hours and neostigmine orally 2.5 mg/8 hours. Limitations: This case report is limited to juvenile ocular myasthenia gravis cases with a scarce number of cases and rare cases in children. Contribution: This case report can be helpful in medical education or used as a reference in making relevant case reports and can be applied in the hospital area when there are cases of juvenile ocular myasthenia gravis.


2020 ◽  
Vol 5 (7) ◽  
pp. 190-193
Author(s):  
Dr. Usha BR. ◽  
◽  
Dr. Nandhini K ◽  
Dr. Chaitra MC ◽  
◽  
...  

Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junction by muscleweakness. Myasthenia gravis can be generalized or localized as ocular myasthenia gravis. Casepresentation: We report an 8-year-old boy who presented with 10 days history of drooping of botheyelids and 8 days history of diplopia. Examination revealed bilateral ptosis. A diagnosis of JuvenileOcular Myasthenia gravis was made when symptoms improved with intramuscular Edrophoniumadministration. He was commenced on oral Neostigmine at a dose of 2mg/Kg/ day,4 hourly individed doses and is on regular follow up and had a good response. Conclusion: Ocular Myastheniagravis (OMG) is a rare disease in itself. A high index of suspicion is required in a juvenile as it iseven rarer.


2012 ◽  
Vol 2 (2) ◽  
pp. 92-93
Author(s):  
Nazmul Haque ◽  
Rukhsana Parvin ◽  
Naser Ahmed ◽  
AKM Rafique Uddin

Myasthenia gravis is the most frequent autoimmune neuromuscular transmission disorder  with incidence of 2-20 patients per million. Its pathophysiology is autoimmune, with  acetylcholine receptor auto antibodies damaging the post-synaptic fold at the muscle  membrane. The diagnostic confirmation of myasthenia gravis is often challenging. Ice-oneyes  test can be used to diagnose this disease for its simplicity, safety and cost-effectiveness. Here we report a case of myasthenia gravis in Enam Medical College Hospital, Savar, Dhaka where ice-on-eyes test was done with improvement of ptosis of the patient. Aim of this case  report is to make aware our physicians to apply this simple bed side test instead of common  traditional edrophonium (tensilon test) test for confirmation of the diagnosis of ocular myasthenia gravis. DOI: http://dx.doi.org/10.3329/jemc.v2i2.12845 J Enam Med Col 2012; 2(2): 92-93  


Sign in / Sign up

Export Citation Format

Share Document